"Building Connections to Improve Health"

 

Friday, April 27, 2018
Text Size

Industry Information

Excel has listed a number of resources found on the Internet here for your convenience.  We feel these resources can be particularly useful for prospective or current Principal Investigators or those considering a career in clinical research. 

Feel free to send us a note at  This email address is being protected from spambots. You need JavaScript enabled to view it.  if you wish to share any links you think would be useful.

Clinical Trials information:
http://www.clinicaltrials.gov/

US Office of Human Subject Research Protections (OHRP):
http://www.hhs.gov/ohrp/about

Clinical Research Standards:
http://www.cc.nih.gov/ccc/clinicalresearch/standards1.html

Convention of Human Rights and Biomedicine – Council of Europe (Spain, April 4, 1997):
http://conventions.coe.int/treaty/en/treaties/html/164.htm

Data Safety Monitoring for Phase I and II Trials:
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-038.html

Ethical Conduct for Research Involving Humans - Policies of the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC), and the Social Sciences and Humanities Research Council of Canada (SSHRC), Tri-Council Working Group (Canada, 1998):
http://pre.ethics.gc.ca/english/policystatement/introduction.cfm

FDA:
http://www.fda.gov

FDA Regulations Relating to Good Clinical Practice and Clinical Trials
http://www.fda.gov/ScienceResearch/SpecialTopics/RunningClinicalTrials/ucm114928.htm

FDA Guidance Documents:
http://www.fda.gov/RegulatoryInformation/Guidances/default.htm

Human Subjects Protections, 21 CFR 50:
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRsearch.cfm?CFRPart=50

Investigational Drugs, 21 CFR 312:
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?CFRPart=312Subpart D--Responsibilities of Sponsors and Investigators 

   § 312.50 - General responsibilities of sponsors. 
   § 312.52 - Transfer of obligations to a contract research organization. 
   § 312.53 - Selecting investigators and monitors. 
   § 312.54 - Emergency research under 50.24 of this chapter. 
   § 312.55 - Informing investigators. 
   § 312.56 - Review of ongoing investigations. 
   § 312.57 - Recordkeeping and record retention. 
   § 312.58 - Inspection of sponsor's records and reports. 
   § 312.59 - Disposition of unused supply of investigational drug. 
   § 312.60 - General responsibilities of investigators. 
   § 312.61 - Control of the investigational drug. 
   § 312.62 - Investigator recordkeeping and record retention. 
   § 312.64 - Investigator reports. 
   § 312.66 - Assurance of IRB review. 
   § 312.68 - Inspection of investigator's records and reports. 
   § 312.69 - Handling of controlled substances. 
   § 312.70 - Disqualification of a clinical investigator.

Investigational Devices, 21 CFR 812:
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?CFRPart=812

Good Clinical Practice Home Page:
http://www.fda.gov/ScienceResearch/SpecialTopics/RunningClinicalTrials/default.htm

Guidance for Industry E6 Good Clinical Practice: Consolidated Guidance (April 1996):
http://www.fda.gov/RegulatoryInformation/Guidances/ucm122049.htm

Good Clinical Practice: Consolidated Guidance - International Conference on Harmonisation (ICH):
http://www.ich.org/products/guidelines.html

Guidelines for Good Clinical Practice for Trials on Pharmaceutical Products – Geneva, World Health Organization (1995):
http://www.who.int/topics/pharmaceutical_products/en/

National Library of Medicine (NLM):
http://www.nlm.nih.gov/

National Statement on Ethical Conduct in Research Involving Humans – National Health and Medical Research Council (Australia, 1999): http://www.nhmrc.gov.au/publications/synopses/e35syn.htm

US Office of Human Subjects Research (OHSR):
http://ohsr.od.nih.gov

The Common Rule: 45 CFR Part 46 Protecting Human Subjects:
http://ohsr.od.nih.gov/guidelines/45cfr46.html

Nuremberg Code (from the Nuremberg Military Tribunal, 1947):
http://ohsr.od.nih.gov/guidelines/nuremberg.html

Declaration of Helsinki (World Medical Association, 1964, '75, '83, '89, '96, 2000):
http://ohsr.od.nih.gov/guidelines/helsinki.html

Belmont Report (National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1979):
http://ohsr.od.nih.gov/guidelines/belmont.html

Comparison of FDA and HHS Human Subject Protection Regulations:
http://www.fda.gov/ScienceResearch/SpecialTopics/RunningClinicalTrials/EducationalMaterials/ucm112910.htm

IRB-member training:
http://ohsr.od.nih.gov/IRBCBT/intro.php

To find current Federal Wide Assurance (FWA) Numbers:
http://www.hhs.gov/ohrp/assurances/assurances_index.htmll

Professional Affiliations:

Association of Clinical Research Professionals (ACRP): www.acrpnet.org

Drug Information Association (DIA): www.diahome.org

Society of Clinical Research Associates (SOCRA): www.socra.org

Applied Clinical Trials (on-line publication): www.actmagazine.com/appliedclinicaltrials